ERAS Chart
- 52-Week Range: $0.00 - $0.00
- Market Capitalization: $678.75M
- Short Percentage: 0%
- Target Price: $23.50
- Shares Outstanding: 121.86M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
ERAS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Erasca Strengthens Clinical and Commercial Leadership with Three Key AppointmentsGlobeNewsWire | May 25th
- Erasca to Present at the Bank of America Securities 2022 Healthcare ConferenceGlobeNewsWire | May 3rd
- Erasca Reports Fourth Quarter 2021 Financial Results and Business UpdatesGlobeNewsWire | March 24th
- Erasca Announces Six Poster Presentations at the 2022 AACR Annual MeetingGlobeNewsWire | March 8th
- Erasca to Present at the Guggenheim Healthcare Talks 2022 Oncology DayGlobeNewsWire | February 3rd
- Erasca Strengthens Leadership Team with Two Key Executive AppointmentsGlobeNewsWire | January 18th
- Erasca to Present at the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire | January 4th
Company Info
Website: https://www.erasca.com
Address: 10835 Road to the Cure, San Diego, CA, United States, 92121
Sector: N/A
Industry: N/A
Full time employees: 123
Address: 10835 Road to the Cure, San Diego, CA, United States, 92121
Sector: N/A
Industry: N/A
Full time employees: 123
$ERAS what happened?
$ERAS Don't hold!!! Buy it
$ERAS yeeeeeee haw
$ERAS Here we go!!!
$ERAS We will not sell!
$ERAS buy and HODL
$ERAS HOLDING STRONG FOR ALL OF YOU
$ERAS taking off soon
$ERAS cup and handle dont play
$ERAS Shorts talk the talk but cant walk the walk